Skip to content

13F-HR filed by Euclidean Capital LLC

Euclidean Capital LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 12 holding rows worth $906,766,414.

Accession
0001012975-24-000483
Filed
2024-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 12 entries on the cover page, a total value of $906,766,414 stated on the cover page (in dollars after the unit check, H1), rows summing to $906,766,414 with VALUE read as dollars as filed, 13F file number 028-20777. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS1,202,804$690,120,823dollars as filed
ISHARES TR46429B598MSCI INDIA ETF2,425,144$141,943,678dollars as filed
Vanguard FTSE All-World ex-US ETF922042775SHS507,600$31,978,800dollars as filed
FOGHORN THERAPEUTICS INC344174107COMMON STOCK1,573,761$14,651,715dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM989,410$10,141,453dollars as filed
ALECTOR INC014442107COMMON STOCK1,307,858$6,094,618dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM2,627,643$3,915,188dollars as filed
23ANDME HOLDING CO90138Q108CLASS A COM10,243,122$3,585,093dollars as filed
TENAYA THERAPEUTICS INC87990A106COM1,015,705$1,960,311dollars as filed
RAPT THERAPEUTICS INC75382E109COM657,899$1,322,377dollars as filed
SURROZEN INC86889P208COMMON STOCK87,696$1,050,598dollars as filed
SURROZEN INC86889P117*W EXP 08/01/203170,833$1,760dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-24-000483this filing2024-11-14acceptance time not in the bulk data set